当前位置:首页 / 清开灵注射液对脑出血患者神经功能及炎性因子水平的影响
专栏:民族医药研究 | 更新时间:2025-02-21
|
清开灵注射液对脑出血患者神经功能及炎性因子水平的影响
Effects of Qingkailing injection on neurological function and inflammatory factor levels in patients with intracerebral hemorrhage

内科 202419卷06期 页码:633-636

作者机构:江西省上饶市中医院,上饶市 334000

DOI:10.16121/j.cnki.cn45⁃1347/r.2024.06.10

  • 中文简介
  • 英文简介
  • 参考文献

目的 探究清开灵注射液对脑出血(ICH)患者神经功能及炎性因子水平的影响。方法 纳入86例ICH患者,按随机数字表法将其分为对照组(43例,常规治疗)、观察组(43例,常规治疗+清开灵注射液),两组均连续治疗2周。比较两组治疗前后的神经功能[美国国立卫生院脑卒中量表(NIHSS)评分、改良爱丁堡-斯堪的纳维亚脑卒中评分量表(MESSS)评分]和炎性因子[血清超敏C反应蛋白(hs-CRP)、白细胞介素(IL)-1β、IL-6、肿瘤坏死因子α(TNF-α)]水平,以及治疗期间不良反应发生情况。结果 治疗2周后,两组NIHSS、MESSS评分和血清hs-CRP、IL-1β、IL-6、TNF-α水平均下降,且观察组下降更明显(均P<0.05);两组不良反应差异无统计学意义(P>0.05)。结论 清开灵注射液应用于ICH患者中,可改善神经功能,降低炎性因子水平,且安全性高。

Objective To investigate the effects of Qingkailing injection on neurological function and inflammatory factor levels in patients with intracerebral hemorrhage (ICH). Methods A total of 86 patients with ICH were included and divided into a control group (43 cases, conventional treatment) or an observation group (43 cases, conventional treatment + Qingkailing injection) using the random number table method, and both groups were treated continuously for 2 weeks. The neurological function (National Institutes of Health Stroke Scale [NIHSS] score and modified Edinburgh Scandinavia Stroke Scale [MESSS] score) and levels of inflammatory factors (serum hypersensitive C-reactive protein [hs-CRP], interleukin [IL]-1β, IL-6, tumor necrosis factor-α [TNF-α]) before and after treatment, as well as the occurrence of adverse reactions during treatment, were compared between the two groups. Results After 2 weeks of treatment, NIHSS and MESSS scores and serum hs-CRP, IL-1β, IL-6, and TNF-α levels decreased in the two groups, and the decreases were more significant in the observation group (all P<0.05); there was no statistically significant difference in the adverse reaction between the two groups (P>0.05). Conclusion Qingkailing injection can improve neurological function and reduce levels of inflammatory factors when treating patients with ICH, with high safety.

4

浏览量

0

下载量

0

CSCD

工具集